What is the best first-line antihypertensive medication for a 50-year-old Black female with uncomplicated hypertension?

Best First-Line Antihypertensive for a 50-Year-Old Black Female

Start with a thiazide-type diuretic (chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 25-50 mg daily) or a calcium channel blocker (CCB) as first-line therapy. 1

Primary Recommendation

The 2017 ACC/AHA guideline explicitly states that thiazide-type diuretics and CCBs are more effective in lowering blood pressure when given as monotherapy or as initial agents in Black patients with hypertension 1. This recommendation is based on both superior blood pressure reduction and better clinical outcomes in this population.

Why Thiazides or CCBs for Black Patients?

• Thiazide-type diuretics are superior to drugs that inhibit the renin-angiotensin system (ACE inhibitors, ARBs, beta-blockers) for prevention of cardiovascular outcomes in Black patients 1
• The CCB amlodipine is as effective as chlorthalidone and more effective than the ACE inhibitor lisinopril in reducing blood pressure, cardiovascular disease, and stroke events in Black patients 1
• High-quality evidence from Cochrane reviews demonstrates that first-line low-dose thiazides reduce mortality, total cardiovascular events, stroke, and coronary heart disease 2, 3

Specific Dosing Guidance

For optimal endpoint protection, use:

• Chlorthalidone 12.5-25 mg daily (preferred thiazide)
• Hydrochlorothiazide 25-50 mg daily (alternative thiazide)
• Lower doses are either unproven or less effective in clinical outcome trials 1

Why Not ACE Inhibitors or ARBs First-Line?

Black patients have reduced responsiveness to monotherapy with ACE inhibitors and ARBs compared to thiazides and CCBs 4. Additionally:

• Black patients have a greater risk of angioedema with ACE inhibitors 1
• ACE inhibitors/ARBs are recommended in Black patients specifically when there is diabetes with nephropathy or heart failure, but offer no advantage over diuretics or CCBs in uncomplicated hypertension 1

Clinical Outcomes Data

The evidence strongly favors thiazides and CCBs in Black patients:

• Thiazides versus beta-blockers: Thiazides reduce total cardiovascular events (ARR 0.6%) and withdrawals due to adverse effects (ARR 2.2%) 2
• Thiazides versus CCBs: Thiazides reduce total cardiovascular events (ARR 1.0%) and heart failure (ARR 1.2%) 2
• Thiazides versus ACE inhibitors: Thiazides reduce stroke (ARR 0.6%) and withdrawals due to adverse effects (ARR 1.0%) 2

Important Caveats

When to Add or Switch to Other Agents

Most Black patients with hypertension require ≥2 antihypertensive medications to achieve adequate blood pressure control 1. If blood pressure is >15 mmHg systolic or >10 mmHg diastolic above goal, start with combination therapy first-line 4.

Single-tablet combinations that include either a diuretic or CCB may be particularly effective in achieving blood pressure control in Black patients 1.

When ACE Inhibitors/ARBs Are Indicated

Reserve ACE inhibitors or ARBs as first-line agents when your patient has:

• Chronic kidney disease 1
• Heart failure 1
• Diabetes with nephropathy 1

In these specific conditions, the benefits of renin-angiotensin system blockade outweigh the reduced blood pressure response seen in Black patients.

Practical Algorithm

1. Uncomplicated hypertension in a 50-year-old Black female: Start thiazide diuretic (chlorthalidone 12.5-25 mg) or CCB (amlodipine 5-10 mg)
2. If blood pressure >15/>10 mmHg above goal: Start combination therapy with thiazide + CCB or thiazide + ACE inhibitor/ARB
3. If CKD, heart failure, or diabetes with nephropathy present: Include ACE inhibitor or ARB in the regimen (typically as part of combination therapy with a diuretic or CCB)
4. If inadequate response to 3 drugs: Evaluate for resistant hypertension 1